Back to top

Accenture Stock (ACN) Opinions on Analyst Ratings and Congressional Activity

Analyst views emerge: Recent analyst commentary on social media highlights UBS reiterating a $275 buy rating for Accenture while Cowen raised its target to $173 from $151 with a hold stance. Discussions note the firm's strong cash position and focus on enterprise technology services amid evolving AI demands.

Political trades surface: Attention turned to filings showing a Minnesota representative sold her full position in Accenture shares in mid-August, prompting questions about timing relative to committee roles in contracting. Observers on social media linked this activity to broader scrutiny of public officials' market moves without speculating on future performance.

Stock recovery noted: Market participants discussed the shares' rebound of nearly 50 percent since a sharp June drop following softer bookings, with the next earnings report expected in early October. Sentiment remains mixed as users weigh operational resilience against potential shifts in client spending patterns.

Note: This discussion summary was generated from an AI condensation of post data.

Accenture Insider Trading Activity

ACN Insider Trades

Accenture insiders have traded $ACN stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:

  • JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 5 sales selling 10,498 shares for an estimated $1,710,918.
  • ATSUSHI EGAWA (Co-CEO Asia Pacific) has made 0 purchases and 4 sales selling 4,872 shares for an estimated $863,044.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Accenture Congressional Stock Trading

Members of Congress have traded $ACN stock 14 times in the past 6 months. Of those trades, 4 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Accenture Hedge Fund Activity

We have seen 929 institutional investors add shares of Accenture stock to their portfolio, and 1,512 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Accenture Government Contracts

We have seen $3,652,588,686 of award payments to $ACN over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Accenture Price Targets

Multiple analysts have issued price targets for $ACN recently. We have seen 17 analysts offer price targets for $ACN in the last 6 months, with a median target of $201.0.

Here are some recent targets:

  • Bryan Bergin from TD Cowen set a target price of $151.0 on 06/26/2026
  • Dan Dolev from Mizuho set a target price of $226.0 on 06/23/2026
  • Jonathan Lee from Guggenheim set a target price of $185.0 on 06/22/2026
  • James Faucette from Morgan Stanley set a target price of $130.0 on 06/22/2026
  • James Friedman from Susquehanna set a target price of $140.0 on 06/22/2026
  • David Paige from RBC Capital set a target price of $175.0 on 06/22/2026
  • Arvind Ramnani from Truist Securities set a target price of $150.0 on 06/22/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Accenture PLC (ACN)